JRI Orthopaedics Invited to a Trade Mission in India

JRI Orthopaedics Invited to a Trade Mission in India

JRI Orthopaedics, the multi award winning Sheffield business, was the only orthopaedics company invited to the three-city mission organised by the Department for International Trade, which included a Royal reception. The manufacturer used this opportunity to showcase the very best UK manufacturing excellence and healthcare innovation.

It was a very interesting and useful mission with some excellent contacts made. JRI Orthopaedics has a long history of innovation, manufacturing excellence, supporting cutting-edge research and working in partnership with the NHS to deliver solutions that bring about real efficiencies and patient benefits, said JRI Orthopaedics’ UK general manager Alistair Wheatley.

In order to commemorate the 70th anniversary of the NHS, Sir Malcolm Grant, Chairman of NHS England, CEO of NHS Digital Sarah Wilkinson and the Minister of State for Trade and Export Promotion Baroness Fairhead organised a four-day trade mission. Delegates from NHS Trusts and health care companies visited New Delhi, Mumbai and Hyderabad to hear from and meet senior managers from Indian hospitals, medical institutes, colleges and business.

India’s healthcare market is estimated to grow to $280bn by 2020. With its recent commitment to developing 100 smart cities across the country, demand for innovative healthcare solutions in the Indian healthcare system has never been higher, said Alistair.

JRI Orthopaedics is based in Chapeltown and it specialises in the design, development, and manufacture of orthopaedic implants and surgical instruments. It is wholly owned by the charity Orthopaedic Research UK (ORUK) and has donated millions to fund research into bone and joint disease.

JRI Orthopaedics’ current expanding product portfolio and orthopaedic systems are designed to streamline the delivery of the best solutions in joint reconstruction, repair and regeneration. Moreover, it was the first company in the world of orthopaedics to produce a hip implant with a Hydroxyapatite coating enabling a biological bond with the patient’s bone and so the prospect of a hip for life.

Share this post